Global Interventional Oncology Market Size study, By Product (Ablation, Particle Embolization, Support Devices), and Regional Forecasts 2022-2028

Global Interventional Oncology Market Size study, By Product (Ablation, Particle Embolization, Support Devices), and Regional Forecasts 2022-2028

Global Interventional Oncology Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028.

The Interventional Oncology can be defined as a cancer treatment procedure with minimally invasive techniques in the management of cancer. In Interventional procedure an oncologist performs diagnostic procedures, such as colonoscopies or endoscopies, X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) to enable targeted and precise treatment of cancer tumours. The growing penetration of Cancer worldwide and increasing demand for minimally invasive treatment procedures as well as recent collaboration activities from leading market players are factors that are accelerating the global market demand. For instance, according to World Cancer Research Fund International estimates – as of 2020, around 18.1 million cancer cases were estimated worldwide. Out of these, 9.3 million cases were reported in men and around 8.8 million reported in women. Breast and lung cancers were the most common cancers worldwide, accounting for 12.5% (2.26 million) and 12.2% (2.20 million) of the total number of new cases diagnosed in 2020. Furthermore, leading market players are working towards strategic partnerships and collaborations to develop interventional oncology solutions. For instance, in July 2021, Medical technology firm Terumo Europe and University Medical Centre Utrecht (UMCU) entered in a memorandum of understanding (MoU) to extend their partnership in the field of oncology. Also, growing number of R&D activities towards new cancer therapeutics as well as rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, inadequate distribution of funds for the research purpose, and earth of skilled professionals impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Interventional Oncology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of research and development activities and presence of leading cancer care centers in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing healthcare sector and increasing incidences of cancer cases in the region, would create lucrative growth prospects for the global Interventional Oncology Market across the Asia Pacific region.

Major market players included in this report are:
Alpinion Medical Systems Co. Ltd.
AngioDynamics
Boston Scientific Corporation
Hologic, Inc.
Medtronic Plc.
Merit Medical
Profound Medical
Siemens Healthineers
Teleflex Incorporated
Terumo Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Ablation
Particle Embolization
Support Devices
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Interventional Oncology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Alpinion Medical Systems Co. Ltd.
AngioDynamics
Boston Scientific Corporation
Hologic, Inc.
Medtronic Plc.
Merit Medical
Profound Medical
Siemens Healthineers
Teleflex Incorporated
Terumo Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.